Kadiant Revenue and Competitors
Estimated Revenue & Valuation
- Kadiant's estimated annual revenue is currently $96.4M per year.
- Kadiant's estimated revenue per employee is $162,605
Employee Data
- Kadiant has 593 Employees.
- Kadiant grew their employee count by 18% last year.
Kadiant's People
Name | Title | Email/Phone |
---|---|---|
1 | Director Training | Reveal Email/Phone |
2 | Clinical Director for San Francisco/Peninsula | Reveal Email/Phone |
3 | Regional Director | Reveal Email/Phone |
4 | Region Director | Reveal Email/Phone |
5 | Clinical Director | Reveal Email/Phone |
6 | Associate Region Director | Reveal Email/Phone |
7 | Clinical Director | Reveal Email/Phone |
8 | Region Director | Reveal Email/Phone |
9 | Clinical Director | Reveal Email/Phone |
10 | Region Director | Reveal Email/Phone |
Kadiant Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $212.8M | 1063 | 5% | $65M | N/A |
#2 | $35.6M | 247 | 18% | N/A | N/A |
#3 | $45M | 299 | -4% | $102.6M | N/A |
#4 | $3.2M | 30 | -25% | $21.3M | N/A |
#5 | $34M | 226 | 0% | $42.9M | N/A |
#6 | $3.6M | 34 | -28% | $35M | N/A |
#7 | $0.8M | 10 | N/A | N/A | N/A |
#8 | $12.6M | 90 | -9% | N/A | N/A |
#9 | $17.4M | 124 | 0% | $96.4M | N/A |
#10 | $5.2M | 49 | -25% | $75.6M | N/A |
What Is Kadiant?
Built on the foundation of decades of experience, Kadiant aspires to provide the highest-quality Applied Behavior Analysis (ABA) therapy and related critical services to individuals diagnosed with an autism spectrum disorder (ASD). Our mission is to enable people to live their best lives
keywords:N/AN/A
Total Funding
593
Number of Employees
$96.4M
Revenue (est)
18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15M | 619 | 21% | N/A |
#2 | $163M | 621 | N/A | N/A |
#3 | $119.9M | 623 | 8% | N/A |
#4 | $15M | 627 | N/A | N/A |
#5 | $300M | 633 | 5% | N/A |